Research Hotspots Analysis on Imaging of Pancreatic Neuroendocrine Tumor on Bibliometrics_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 ZHANGXiao ¹ , WANGQi-yan ² , HUANGZi-xing ² ,  SONGBin ²

1. Department of CT/MRI, Leshan People, s Hospital, Leshan 614000, Sichuan Province, China;
2. Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China;

Corresponding author：

SONGBin, Email: cjr.songbin@vip.163.com

Keywords：

Pancreatic neuroendocrine tumor; Research hotspot; Bibliometric

DOI：

10.7507/1007-9424.20150265

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the hotspots from researches on imaging of pancreatic neuroendocrine tumor in recent five years. Methods The bibliographies from research literatures on imaging of pancreatic neuroendocrine tumor from 2010 to 2015 in PubMed database were downloaded. The Bicomb 2.0 bibliographies analysis software was used to count high-frequency of Mesh major topics (MJMEs). SPSS 22.0 statistical software was applied for clustering analysis with MJMEs, then to get the topic hotspots. Results A total of 357 literatures were screened out during the years of 2010-2015. The MJMEs which frequency > 13 were 28. Taken the 28 MJMEs into clustering analysis, then three research hotspots were clustered. Conclusion Researches on imaging of the pancreatic neuroendocrine tumor in recent five years are mainly in terms of imaging techniques, a comparative study of pathology and endoscopic ultrasonography-fine needle aspiration, imaging and disease treatment.

Citation： ZHANGXiao, WANGQi-yan, HUANGZi-xing, SONGBin. Research Hotspots Analysis on Imaging of Pancreatic Neuroendocrine Tumor on Bibliometrics. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2015, 22(8): 1007-1013. doi: 10.7507/1007-9424.20150265 Copy

1.	Hörsch D, Bert T, Schrader J, et al. Pancreatic neuroendocrine neoplasms. Minerva Gastroenterol Dietol, 2012, 58(4):401-426.
2.	郭启勇.实用放射学.第3版.北京:人民卫生出版社, 2007:827.
3.	Ellison TA, Edil BH. The current management of pancreatic neuroendocrine tumors. Adv Surg, 2012, 46:283-296.
4.	崔雷, 刘伟, 闫雷, 等.文献数据库中书目信息共现挖掘系统的开发.现代图书情报技术, 2008, 24(8):70-75.
5.	De Angelis C, Manfrè SF, Bruno M, et al. Hegemony and cost-effec-tiveness of endoscopic ultrasound (EUS) in the field of gastroentero-pancreatic-neuroendocrine tumors (GEP-NETs). Minerva Med, 2014, 105(5):363-370.
6.	Khashab MA, Yong E, Lennon AM, et al. EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors. Gastrointest Endosc, 2011, 73(4):691-696.
7.	Pais SA, Al-Haddad M, Mohamadnejad M, et al. EUS for pancreatic neuroendocrine tumors:a single-center, 11-year experience. Gastrointest Endosc, 2010, 71(7):1185-1193.
8.	Pais SA, Al-Haddad M, Mohamadnejad M, et al. EUS for pancreatic neuroendocrine tumors:a single-center, 11-year experience. Gastro-intest Endosc, 2010, 71(7):1185-1193.
9.	Ishikawa T, Itoh A, Kawashima H, et al. Usefulness of EUS comb-ined with contrast-enhancement in the differential diagnosis of malignant versus benign and preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc, 2010, 71(6):951-959.
10.	Puli SR, Kalva N, Bechtold ML, et al. Diagnostic accuracy of endos-copic ultrasound in pancreatic neuroendocrine tumors:a systematic review and meta analysis. World J Gastroenterol, 2013, 19(23):3678-3684.
11.	Thorlacius H, Kalaitzakis E, Johansson GW, et al. Cystic neuroendo-crine tumor in the pancreas detected by endoscopic ultrasound and fine-needle aspiration:a case report. BMC Res Notes, 2014, 7:510.
12.	Yoon WJ, Daglilar ES, Pitman MB, et al. Cystic pancreatic neuroen-docrine tumors:endoscopic ultrasound and fine-needle aspiration characteristics. Endoscopy, 2013, 45(3):189-194.
13.	Ho HC, Eloubeidi MA, Siddiqui UD, et al. Endosonographic and cyst fluid characteristics of cystic pancreatic neuroendocrine tumours:a multicentre case series. Dig Liver Dis, 2013, 45(9):750-753.
14.	Kawamoto S, Johnson PT, Shi C, et al. Pancreatic neuroendocrine tumor with cyst like changes:evaluation with MDCT. AJR Am J Roentgenol, 2013, 200(3):W283-W290.
15.	Lee JH, Byun JH, Kim JH, et al. Solid pancreatic tumors with unilo-cular cyst-like appearance on CT:differentiation from unilocularc-ystic tumors using CT. Korean J Radiol, 2014, 15(6):704-711.
16.	Luo Y, Dong Z, Chen J, et al. Pancreatic neuroendocrine tumours:correlation between MSCT features and pathological classification. Eur Radiol, 2014, 24(11):2945-2952.
17.	Tatsumoto S, Kodama Y, Sakurai Y, et al. Pancreatic neuroendocrine neoplasm:correlation between computed tomography enhancemen-tpatterns and prognostic factors of surgical and endoscopic ultraso-und-guided fine-needle aspirationbiopsy specimens. Abdom Imaging, 2013, 38(2):358-366.
18.	Utsumi M, Umeda Y, Takagi K, et al. Correlation of computed tomo-graphy imaging features and pathological features of 41 patients with pancreatic neuroendocrine tumors. Hepatogastroenterology, 2015, 62(138):441-446.
19.	Foti G, Boninsegna L, Falconi M, et al. Preoperative assessment of nonfunctioning pancreatic endocrine tumours:role of MDCT and MRI. Radiol Med, 2013, 118(7):1082-1101.
20.	Poultsides GA, Huang LC, Chen Y, et al. Pancreatic neuroendocrine tumors:radiographic calcifications correlate with grade and metastasis. Ann Surg Oncol, 2012, 19(7):2295-2303.
21.	Grözinger G, Grözinger A, Horger M. The role of volume perfusion CT in the diagnosis of pathologies of the pancreas. Rofo, 2014, 186(12):1082-1093.
22.	Kang BK, Kim JH, Byun JH, et al. Diffusion-weighted MRI:useful-ness for differentiating intrapancreatic accessory spleen and small hypervascular neuroendocrine tumor of the pancreas. Acta radiol, 2014, 55(10):1157-1165.
23.	Jang KM, Kim SH, Song KD, et al. Differentiation of solid-type serous cystic neoplasm from neuroendocrine tumour in the pancreas:value of abdominal MRI with diffusion-weighted imaging in comparison with MDCT. Clin Radiol, 2015, 70(2):153-160.
24.	Concia M, Sprinkart AM, Penner A, et al. Diffusion-weighted magnetic resonance imaging of the pancreas diagnostic benefit from an intravoxel incoherent motion model-based 3 b-value analysis. Invest Radiol, 2014, 49(2):93-100.
25.	Barral M, Sebbag-Sfez D, Hoeffel C, et al. Characterization of focal pancreatic lesions using normalized apparent diffusion coefficient at 1.5-Tesla:preliminary experience. Diagn Interv Imaging, 2013, 94(6):619-627.
26.	Kim JH, Eun HW, Kim YJ, et al. Staging accuracy of MR for pancre-atic neuroendocrine tumor and imaging findings according to thetumor grade. Abdom Imaging, 2013, 38(5):1106-1114.
27.	Hwang EJ, Lee JM, Yoon JH, et al. Intravoxel incoherent motion diffusion-weighted imaging of pancreatic neuroendocrine tumors:prediction of the histologic grade using pure diffusion coefficient and tumor size. Invest Radiol, 2014, 49(6):396-402.
28.	Wang Y, Chen Z, Yaghmai V, et al. Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics. J Magn Reson Imaging, 2011, 33(5):1071-1079.
29.	Balachandran A, Tamm EP, Bhosale PR, et al. Pancreatic neuroendocrine neoplasms:diagnosis and management. Abdom Imaging, 2013, 38(2):342-357.
30.	Farrell JM, Pang JC, Kim GE, et al. Pancreatic neuroendocrine tumors:accurate grading with Ki-67 index on fine-needle aspira-tion specimens using the WHO 2010/ENETS criteria. Cancer Cytopathol, 2014, 122(10):770-778.
31.	Hasegawa T, Yamao K, Hijioka S, et al. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy, 2014, 46(1):32-38.
32.	Samad A, Attam R, Jessurun J, et al. Psammoma bodies and abundant stromal amyloid in an endoscopic ultrasound guided fine needleaspirate (EUS-FNA) of a pancreatic neuroendocrine tumor:a potential pitfall. Diagn Cytopathol, 2014, 42(9):766-771.
33.	Siddiqui AA, Kowalski TE, Shahid H, et al. False-positive EUS-guided FNA cytology for solid pancreatic lesions. Gastrointest Endosc, 2011, 74(3):535-540.
34.	Turner BG, Cizginer S, Agarwal D, et al. Diagnosis of pancreatic neoplasia with EUS and FNA:a report of accuracy. Gastrointest Endosc, 2010, 71(1):91-98.
35.	Jang KM, Kim SH, Lee SJ, et al. The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Acta radiol, 2014, 55(2):140-148.
36.	Worhunsky DJ, Krampitz GW, Poullos PD, et al. Pancreatic neuroen-docrine tumours:hypoenhancement on arterial phase computed tomography predicts biological aggressiveness. HPB (Oxford), 2014, 16(4):304-311.
37.	Law JK, Singh VK, Khashab M, et al. Endoscopic ultrasound (EUS)-guided fiducial placement allows localization of small neuroendo-crine tumors during parenchymal-sparing pancreatic surgery. Surg Endosc, 2013, 27(10):3921-3926.
38.	Kunikowska J, Słodkowski M, Koperski Ł, et al. Radioguided surgery in patient with pancreatic neuroendocrine tumour followed by PET/CT scan as a new approach of complete resection evaluation-case report. Nucl Med Rev Cent East Eur, 2014, 17(2):110-114.
39.	Giesel FL, Wulfert S, Zechmann CM, et al. Contrast-enhanced ultra-sound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177Lu/90Y-DOTA-TOC and 213Bi-DOTATOC radiopeptidetherapy. Exp Oncol, 2013, 35(2):122-126.
40.	Deneche T, Baur AD, Ihm C, et al. Evaluation of radiological prognostic factors of hepatic metastases in patients with non-functional pancreatic neuroendocrine tumors. Eur J Radiol, 2013, 82(10):e550-e555.

1. Hörsch D, Bert T, Schrader J, et al. Pancreatic neuroendocrine neoplasms. Minerva Gastroenterol Dietol, 2012, 58(4):401-426.
2. 郭启勇.实用放射学.第3版.北京:人民卫生出版社, 2007:827.
3. Ellison TA, Edil BH. The current management of pancreatic neuroendocrine tumors. Adv Surg, 2012, 46:283-296.
4. 崔雷, 刘伟, 闫雷, 等.文献数据库中书目信息共现挖掘系统的开发.现代图书情报技术, 2008, 24(8):70-75.
5. De Angelis C, Manfrè SF, Bruno M, et al. Hegemony and cost-effec-tiveness of endoscopic ultrasound (EUS) in the field of gastroentero-pancreatic-neuroendocrine tumors (GEP-NETs). Minerva Med, 2014, 105(5):363-370.
6. Khashab MA, Yong E, Lennon AM, et al. EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors. Gastrointest Endosc, 2011, 73(4):691-696.
7. Pais SA, Al-Haddad M, Mohamadnejad M, et al. EUS for pancreatic neuroendocrine tumors:a single-center, 11-year experience. Gastrointest Endosc, 2010, 71(7):1185-1193.
8. Pais SA, Al-Haddad M, Mohamadnejad M, et al. EUS for pancreatic neuroendocrine tumors:a single-center, 11-year experience. Gastro-intest Endosc, 2010, 71(7):1185-1193.
9. Ishikawa T, Itoh A, Kawashima H, et al. Usefulness of EUS comb-ined with contrast-enhancement in the differential diagnosis of malignant versus benign and preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc, 2010, 71(6):951-959.
10. Puli SR, Kalva N, Bechtold ML, et al. Diagnostic accuracy of endos-copic ultrasound in pancreatic neuroendocrine tumors:a systematic review and meta analysis. World J Gastroenterol, 2013, 19(23):3678-3684.
11. Thorlacius H, Kalaitzakis E, Johansson GW, et al. Cystic neuroendo-crine tumor in the pancreas detected by endoscopic ultrasound and fine-needle aspiration:a case report. BMC Res Notes, 2014, 7:510.
12. Yoon WJ, Daglilar ES, Pitman MB, et al. Cystic pancreatic neuroen-docrine tumors:endoscopic ultrasound and fine-needle aspiration characteristics. Endoscopy, 2013, 45(3):189-194.
13. Ho HC, Eloubeidi MA, Siddiqui UD, et al. Endosonographic and cyst fluid characteristics of cystic pancreatic neuroendocrine tumours:a multicentre case series. Dig Liver Dis, 2013, 45(9):750-753.
14. Kawamoto S, Johnson PT, Shi C, et al. Pancreatic neuroendocrine tumor with cyst like changes:evaluation with MDCT. AJR Am J Roentgenol, 2013, 200(3):W283-W290.
15. Lee JH, Byun JH, Kim JH, et al. Solid pancreatic tumors with unilo-cular cyst-like appearance on CT:differentiation from unilocularc-ystic tumors using CT. Korean J Radiol, 2014, 15(6):704-711.
16. Luo Y, Dong Z, Chen J, et al. Pancreatic neuroendocrine tumours:correlation between MSCT features and pathological classification. Eur Radiol, 2014, 24(11):2945-2952.
17. Tatsumoto S, Kodama Y, Sakurai Y, et al. Pancreatic neuroendocrine neoplasm:correlation between computed tomography enhancemen-tpatterns and prognostic factors of surgical and endoscopic ultraso-und-guided fine-needle aspirationbiopsy specimens. Abdom Imaging, 2013, 38(2):358-366.
18. Utsumi M, Umeda Y, Takagi K, et al. Correlation of computed tomo-graphy imaging features and pathological features of 41 patients with pancreatic neuroendocrine tumors. Hepatogastroenterology, 2015, 62(138):441-446.
19. Foti G, Boninsegna L, Falconi M, et al. Preoperative assessment of nonfunctioning pancreatic endocrine tumours:role of MDCT and MRI. Radiol Med, 2013, 118(7):1082-1101.
20. Poultsides GA, Huang LC, Chen Y, et al. Pancreatic neuroendocrine tumors:radiographic calcifications correlate with grade and metastasis. Ann Surg Oncol, 2012, 19(7):2295-2303.
21. Grözinger G, Grözinger A, Horger M. The role of volume perfusion CT in the diagnosis of pathologies of the pancreas. Rofo, 2014, 186(12):1082-1093.
22. Kang BK, Kim JH, Byun JH, et al. Diffusion-weighted MRI:useful-ness for differentiating intrapancreatic accessory spleen and small hypervascular neuroendocrine tumor of the pancreas. Acta radiol, 2014, 55(10):1157-1165.
23. Jang KM, Kim SH, Song KD, et al. Differentiation of solid-type serous cystic neoplasm from neuroendocrine tumour in the pancreas:value of abdominal MRI with diffusion-weighted imaging in comparison with MDCT. Clin Radiol, 2015, 70(2):153-160.
24. Concia M, Sprinkart AM, Penner A, et al. Diffusion-weighted magnetic resonance imaging of the pancreas diagnostic benefit from an intravoxel incoherent motion model-based 3 b-value analysis. Invest Radiol, 2014, 49(2):93-100.
25. Barral M, Sebbag-Sfez D, Hoeffel C, et al. Characterization of focal pancreatic lesions using normalized apparent diffusion coefficient at 1.5-Tesla:preliminary experience. Diagn Interv Imaging, 2013, 94(6):619-627.
26. Kim JH, Eun HW, Kim YJ, et al. Staging accuracy of MR for pancre-atic neuroendocrine tumor and imaging findings according to thetumor grade. Abdom Imaging, 2013, 38(5):1106-1114.
27. Hwang EJ, Lee JM, Yoon JH, et al. Intravoxel incoherent motion diffusion-weighted imaging of pancreatic neuroendocrine tumors:prediction of the histologic grade using pure diffusion coefficient and tumor size. Invest Radiol, 2014, 49(6):396-402.
28. Wang Y, Chen Z, Yaghmai V, et al. Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics. J Magn Reson Imaging, 2011, 33(5):1071-1079.
29. Balachandran A, Tamm EP, Bhosale PR, et al. Pancreatic neuroendocrine neoplasms:diagnosis and management. Abdom Imaging, 2013, 38(2):342-357.
30. Farrell JM, Pang JC, Kim GE, et al. Pancreatic neuroendocrine tumors:accurate grading with Ki-67 index on fine-needle aspira-tion specimens using the WHO 2010/ENETS criteria. Cancer Cytopathol, 2014, 122(10):770-778.
31. Hasegawa T, Yamao K, Hijioka S, et al. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy, 2014, 46(1):32-38.
32. Samad A, Attam R, Jessurun J, et al. Psammoma bodies and abundant stromal amyloid in an endoscopic ultrasound guided fine needleaspirate (EUS-FNA) of a pancreatic neuroendocrine tumor:a potential pitfall. Diagn Cytopathol, 2014, 42(9):766-771.
33. Siddiqui AA, Kowalski TE, Shahid H, et al. False-positive EUS-guided FNA cytology for solid pancreatic lesions. Gastrointest Endosc, 2011, 74(3):535-540.
34. Turner BG, Cizginer S, Agarwal D, et al. Diagnosis of pancreatic neoplasia with EUS and FNA:a report of accuracy. Gastrointest Endosc, 2010, 71(1):91-98.
35. Jang KM, Kim SH, Lee SJ, et al. The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Acta radiol, 2014, 55(2):140-148.
36. Worhunsky DJ, Krampitz GW, Poullos PD, et al. Pancreatic neuroen-docrine tumours:hypoenhancement on arterial phase computed tomography predicts biological aggressiveness. HPB (Oxford), 2014, 16(4):304-311.
37. Law JK, Singh VK, Khashab M, et al. Endoscopic ultrasound (EUS)-guided fiducial placement allows localization of small neuroendo-crine tumors during parenchymal-sparing pancreatic surgery. Surg Endosc, 2013, 27(10):3921-3926.
38. Kunikowska J, Słodkowski M, Koperski Ł, et al. Radioguided surgery in patient with pancreatic neuroendocrine tumour followed by PET/CT scan as a new approach of complete resection evaluation-case report. Nucl Med Rev Cent East Eur, 2014, 17(2):110-114.
39. Giesel FL, Wulfert S, Zechmann CM, et al. Contrast-enhanced ultra-sound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177Lu/90Y-DOTA-TOC and 213Bi-DOTATOC radiopeptidetherapy. Exp Oncol, 2013, 35(2):122-126.
40. Deneche T, Baur AD, Ihm C, et al. Evaluation of radiological prognostic factors of hepatic metastases in patients with non-functional pancreatic neuroendocrine tumors. Eur J Radiol, 2013, 82(10):e550-e555.

Previous Article
急性梗阻性化脓性胆管炎的微创治疗
Next Article
Research Progress of Long Noncoding RNAs in Common Digestive System Neoplasms

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Research Hotspots Analysis on Imaging of Pancreatic Neuroendocrine Tumor on Bibliometrics

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content